Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-10 · accession 0001209191-23-009174 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-02-14 | 2023-02-10+ | VRTX | ALTSHULER DAVID | EVP, CSO, Gbl Research | F - Tax | $296.82 | -9,451 | 65.2K | -13% | -$2.81M |
| M | 2023-02-14 | 2023-02-13 | VRTX | ALTSHULER DAVID | EVP, CSO, Gbl Research | S - Sale | $298.90 | -4,798 | 54.9K | -8% | -$1.43M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-13 | F | D | 5,990 | $298.26 | 59,194 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-13 | S | D | 245 | $296.44 | 58,949 | D | — | — | (F2) Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F3) Open market sales reported on this line occurred at a weighted average price of $296.44 (range $295.84 to $296.57). |
| 3 | Common | Common Stock | 2023-02-13 | S | D | 2,160 | $298.47 | 56,789 | D | — | — | (F4) Open market sales reported on this line occurred at a weighted average price of $298.47 (range $297.85 to $298.82). (F2) Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2023-02-13 | S | D | 500 | $300.23 | 54,396 | D | — | — | (F6) Open market sales reported on this line occurred at a weighted average price of $300.23 (range $299.96 to $300.63). (F2) Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2023-02-10 | F | D | 3,461 | $294.33 | 65,184 | D | — | — | |
| 6 | Common | Common Stock | 2023-02-13 | S | D | 1,893 | $299.36 | 54,896 | D | — | — | (F5) Open market sales reported on this line occurred at a weighted average price of $299.36 (range $298.86 to $299.83). (F2) Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |